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Delay in seeking medical attention after discovery of a breast
symptom is an important problem (Richards et al, 1999). The
thrust of public policy is to encourage early detection and diag-
nosis of breast cancer in order to deliver prompt treatment and
improve outcome. A meta-analysis of 12 studies on delay reported
that 34.2% (range 9.9–56.0%) of subjects (total = 8781) delayed
more than 3 months (Facione, 1993). Personal and social variables
such as: symptom attribution (Hackett et al, 1973; Averill, 1987;
Nichols, 1993), beliefs and attitudes (Antonowsky and Hartman,
1974; Greer, 1974; Timko, 1987), the nature of symptoms (Adam
et al, 1980; MacArthur and Smith, 1981; Caplan, 1995), health
awareness (Huguley and Brown, 1981; Darrow at al, 1987; Zervas
et al, 1993), personality characteristics (Douglas and Druss, 1987;
Keinan et al, 1991–92; Phelan et al, 1992) socio-demographic
factors (Hackett at al, 1973; Elwood and Moorehead, 1980; Eley at
al, 1994, Ramirez et al, 1999) and ethnicity (Richardson et al,
1992; Gregorio et al, 1993; Eley at al, 1994), may all determine
when women present with symptoms and when treatment begins.
The majority of published studies focus on delay in presentation
with breast cancer symptoms rather than all breast symptoms.
However, all women with breast symptoms experience worry and
distress, regardless of whether they turn out to have malignant
disease (Howard and Harvey, 1998). We therefore studied compre-
hensively the reasons that lead to delay in presentation in all symp-
tomatic referrals to an NHS teaching hospital breast clinic, irre-
spective of final diagnosis. The aim of the present investigation
was to isolate the risk factors for women who tend to have long
delays, and who may therefore be targeted for future intervention.
We hypothesized that ‘long delayers’ and ‘short delayers’
would have different psychosocial profiles (i.e. increased General
Health Questionnaire (GHQ) scores – indicative of psychiatric
morbidity, lower socio-economic status, older age and belonging
to an ethnic minority group), and that these factors would also
relate to system delay, in line with US data (Richardson et al,
1992; Hunter et al, 1993). We also hypothesized that fear and/or
denial would be positively associated with patient delay (Darrow
at al, 1987; Zervas et al, 1993; Caplan, 1995). Regarding system
delay, we hypothesized that symptoms other than a lump would be
associated with increased delay, whereas a cancer diagnosis would
be associated with decreased delay.
SUBJECTS AND METHODS
All 708 women referred to the Breast Clinic aged between 40 and
75 years from September 1995 to January 1997 were eligible for
the study. Patients were excluded if they had cognitive impair-
ment, had been diagnosed with breast cancer in the past 5 years, or
were referred either due to a family history of breast cancer or for
a second opinion or from the national breast cancer screening
service. Four women declined to participate and 12 were not
assessed because of logistic problems. In total, 692 (97.7%) symp-
tomatic women were interviewed. Patients were approached by 
a researcher in the waiting room before their first specialist
consultation. Informed consent was obtained from participants.
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measure delay, presenting symptom(s), mammogram history,
previous breast problems, reasons for delay, beliefs and attitudes to
cancer. Patient delay was operationally defined as the time
elapsing between symptom self-discovery and the first presenta-
tion to a medical provider to seek evaluation. Care was taken to
avoid encouraging retrospective falsification in estimates of delay,
which might be induced by signalling disapproval or conveying
any expectation on when presentation was expected. Subjects were
helped to date symptom onset with specific memory probes and
anchor points. System delay was defined as the time between a
woman’s first medical evaluation of self-discovered breast symp-
toms and first consultation with a breast specialist, and was
assessed by recording dates of first presentation in primary 
care and time for referral to reach the Breast Clinic. Dates were
verified using general practitioner (GP) and hospital records. The
General Health Questionnaire (GHQ-12) (Goldberg and Williams,
1988) was used to measure psychiatric morbidity and the ‘Health
Awareness Assessment’, designed and piloted for this study,
elicited patients’ intention to seek medical consultation for a range
of ten different physical symptoms including a breast lump, persis-
tent headache, coughing up blood, irregular periods. Clinical staff
used a short semi-structured interview to collate patients’ full
medical history and risk factors for breast cancer.
Social and demographic data included marital status, religion,
ethnicity (by self-definition), occupation, years of education and
educational attainment. Information about appropriate utilization
of mammographic screening services was collected, as was failure
to keep clinic appointments for the current episode, GP attendance
in the previous year and preference for a female consultant.
RESULTS
Sample characteristics
The characteristics of the sample are shown in Table 1. Eighty-
seven (12.6%) women had a final diagnosis of breast cancer.
Overall, 421 women (60.8% of whole sample) presented with a
breast lump with or without pain, 62 of whom were later diagnosed
with breast cancer (c2 = 4.54, P = 0.03). Breast pain, with or
without another associated breast symptom occurred in a similar
proportion of patients irrespective of final diagnosis. Other symp-
toms such as ‘tenderness’, ‘thickening’, nipple discharge, skin
rashes etc., occurred more frequently in the non-cancer group (see
Table 1).
Women were regarded as having missed a mammogram if,
according to their age (i.e. 50–64 years) they would have been
expected to have been invited to participate in the National
Screening Programme. This percentage was significantly higher
for breast cancer patients when compared with women with other
breast symptoms. Only 21 women failed to keep clinic appoint-
ments for the current episode (one of whom turned out to have
cancer).
Distribution of patient and system delay
Results are given in Table 2. For the total sample (n = 692) median
patient delay was 13 days. The range was from 0 to 10 958 days.
The distribution was highly skewed with a few subjects showing
extreme delay hence logarithmic transformation was undertaken
for presentation and statistical analyses (Figure 1). Patients who
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Table 1 Characteristics of breast cancer patients and those with other breast symptoms
Variable Cancer Benign All Statistics
(n =87) (n = 605) (n = 692)
Mean age (years) at symptom discovery 60.0 ± 10.5 50.7 ± 9.1 51.8 ± 9.8 Z = 7.4, P < 0.001c
(Median 63) (Median 48) (Median 49)
Presenting symptom(s) c2 = 48.2, P < 0.001b
Painful breast lump 18 (20.7%) 115 (19.0%) 133 (19.2%)
Painless breast lump 35 (40.2%) 178 (29.4%) 213 (30.8%)
Breast lump + other sx 9 (10.3%) 66 (10.9%) 75 (10.8%)
Other breast symptoms 25 (28.7%) 246 (40.7%) 271 (39.2%)
Socio-economic statusa c2 = 5.7, P = 0.2b
I 3 (3.4%) 41 (6.8%) 44 (6.4%)
II 13 (14.9%) 132 (21.8%) 145 (21.0%)
III 25 (28.7%) 184 (30.4%) 209 (30.2%)
IV 20 (23.0%) 113 (18.7%) 133 (19.2%)
V 26 (29.9%) 135 (22.3%) 161 (23.3%)
Marital status c2 = 12.6, P = 0.01b
Single 9 (10.3%) 101 (16.7%) 110 (15.9%)
Married/remarried 49 (56.3%) 333 (55.0%) 382 (55.2%)
Divorced 13 (14.9%) 124 (20.5%) 137 (19.8%)
Widowed 16 (18.4%) 47 (7.8%) 63 (9.1%)
Ethnicity c2 = 17.5, P = 0.004b
British 65 (74.7%) 335 (55.4%) 400 (57.8%)
Other White 9 (10.3%) 99 (16.4%) 108 (15.6%)
African 1 (1.1%) 42 (6.9%) 43 (6.2%)
Afro-Caribbean 6 (6.9%) 99 (16.4%) 105 (15.2%)
Asian 6 (6.9%) 30 (5.0%) 36 (5.2%)
Family history of breast cancer 11 (16.7%) 68 (18.2%) 98 (18.7%) c2 = NS
No. of GP consultations in previous year 3.5 ± 0.9 3.3 ± 0.8 3.4 ± 0.8 Z = 1.3, P = 0.2c
Mammogram 137 (22.6%) 31 (35.6%) 168 (24.3%) c2 = 6.9, P = 0.01
Numbers in parentheses are column percentages. aStandard Occupational Classification (SOC). bTest for heterogeneity.
cWilcoxon rank sums test.were subsequently diagnosed as suffering from malignant disease
showed a slight non-significant tendency to present earlier than
those whose symptoms were benign. When extreme delay was
considered, 5.0% of patients with benign breast symptoms versus
9.2% of cancer patients delayed presentation over 1 year (c2 = 8.5,
df = 3, P = 0.04).
Regarding system delay, the majority of patients were seen in
the clinic within 2–4 weeks, but others were sent away with no
further investigation or referral; median 18 days, range was from 0
to 2889 days (8.1 years) (Figure 2 and Table 2). Patients with
breast symptoms of a benign nature experienced significantly
greater system delay. Cancer patients were twice as likely to see a
breast specialist within three weeks of contact with their GP than
patients who had benign breast symptoms, suggesting that GPs are
more alert to certain symptoms and signs that were later shown to
be caused by malignancy (24 (27.6%) vs 237 (39.2%); c2 = 5.4, 
df = 1, P = 0.02). There was no correlation between patient and
system delay (Kendall’s Tau: r = 0.05).
Long patient delay analysis
For statistical analyses, patients were divided into ‘long’ and
‘short’ delayers. Long delayers were those presenting >27 days
from symptom discovery. The cut-off point of 27 days used to
define delay in this study was prompted by the preferred statistical
analytic technique to explore the data (logistic regression). Only
17% of patients in the present study delayed over 3 months,
compared to 35% delaying for 4 weeks or more. Using the larger
group maximizes the chances of reliably explaining the observed
variation in delay.
Presenting symptom and delay
Women’s presenting symptoms were investigated in relation to
short and long presentation delay, and results of an analysis 
of variance showed no significant differences (F = 0.10, df = 4, 
P = 0.4). However, when presenting symptom was simply divided
into lump/no lump and pain/no pain, statistically significant differ-
ences in delay emerged. Sixty-six per cent of women with a breast
lump presented to their doctor within 27 days from symptom
discovery, compared to 34% of those without a lump (c2 = 13.9, 
df = 1, P = 0.001). Of patients with breast tenderness or pain, 
76% presented to their doctor within 27 days from symptom
discovery, compared to 62% of those without pain (c2 = 8.8, 
df = 1, P = 0.003).
Reasons for delay
Whole sample
Reasons given by patients to justify their delay are given in Table
3. When patients mentioned more than one reason, we identified
the most important by further questioning. Over half of ‘long
delays’ occurred in women who believed that their symptom was
not serious and therefore did not require medical attention. Women
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Table 2 Patient and system delay
Variable Cancer Benign All Statistics
(n = 87) (n = 605) (n = 692)
Patient delay (days)
Mean (±SD) 80 ± 172 129 ± 700 122.9 ± 658
Median 7 14 13 Z = 0.88, P = 0.38
System delay (days)
Mean (±SD) 22.9 ± 50 48.2 ± 180 44.8 ± 170
Median 14 18 18 Z = 3.46, P = 0.0005
Wilcoxon rank sums test: cancer vs benign.
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Figure 1 Distribution of log patient delay (days) +1 for cancer patients and those with other breast symptomswho delayed specifically because they feared a cancer diagnosis
had the highest median delay (91 days). When a reason for delay
was not given and when women presented as soon as possible,
delay reason was coded as ‘other’.
Cancer vs non-cancer
Overall, cancer patients and patients with benign breast disease
differed significantly in their reasons for delay (c2 = 13.3, df = 4, 
P = 0.01): patients who subsequently were diagnosed with cancer
delayed presentation because they were scared more often than
women with benign conditions (11.5% and 4.0% respectively) and
were less likely to consider their symptom to be ‘not serious’
(21.8% vs 35.0%).
When ‘long delayers’ only were considered, cancer patients
delayed presentation because they were scared more often than
women with benign disease (22.2% and 5.1% respectively: c2 =
10.8, df = 1, P = 0.001) (Table 4). There was no significant differ-
ence between the groups in terms of thinking that the symptom
would go away (c2 = 1.6, df = 1, P = 0.2) or other beliefs. These
results suggest that some women anticipated their eventual diag-
nosis of breast cancer. We examined this further by cross-tabu-
lating attribution (benign/malignant) by diagnosis, for all subjects.
Of people with benign breast symptoms, 108 (17.8%) thought they
had cancer. Of those 87 women with cancer, 55 (63.2%) suspected
a correct diagnosis; 32 (36.8%) thought they had a less serious
condition (c2 = 16.9, df = 1, P = 0.001).
In order to investigate psychosocial and demographic variables
associated significantly with long patient delay (log patient delay
(days) + 1), a logistic regression model was constructed. The
results and significant variables are shown in Table 5. ‘Long
delayers’ were characterized by poor health awareness about
hypothetical breast symptoms, the tendency to minimize the
significance of their symptom and by fear and higher levels of
psychological morbidity (GHQ-12 scores). Variables entered
which did not contribute noticeably to the variance included
marital status, social class, ethnicity, educational attainment,
psychiatric history, history of benign breast symptoms, family
history and previous mammograms. Patient delay in cancer
patients and those with benign breast symptoms was predicted by
the same variables, therefore a breakdown according to diagnosis
is not given.
As argued above, a cut-off of 27 days was used to define long
delay. However, to aid comparison with other studies the same
analysis was conducted with a 90-day cut-off. The maximum re-
scaled R2 was 0.21. The same explanatory variables emerged but
with additions, namely preferring a female consultant: odds ratio
(OR) 2.16 (95% confidence intervals (CI) 1.3–3.5); having a
recent GP consultation (within 1 year of current episode): OR 1.35
(95% CI 1.03–1.78); and presenting with a lump: OR 0.56 (95% 
CI 0.36–0.89).
A linear regression model was constructed to predict changes in
log system delay (Table 6). Women with longer patient delays and
Symptomatic referrals to breast clinic 745
British Journal of Cancer (2000) 82(3), 742–748 © 2000 Cancer Research Campaign
0.0 1.2 1.4 1.6 1.7 1.9 2.1 2.3 2.5 2.7 2.9 3.1 3.3 3.5 3.7 3.9 4.1 4.3 More
Log delay
0 1.6 2.5 4.0 5.0 7.9 12.6 20.0 31.6 50.1 79.4
125.9
199.5
316.2
501.2
793.3
1258.9
1955.2
More
Delay days
Cancer
Benign
W
o
m
e
n
 
(
%
)
45
40
35
30
25
20
15
10
5
0
Figure 2 Distribution of log system delay (days) +1 for cancer patients and those with other breast symptoms
Table 3 Reasons for patient delay for the whole sample
Reason for Delay Frequency Mean delay Median delay Delay range
(days) and s.d. (days) (days)
Thought the symptom would  85 (12.3%) 127 ± 434 26 1–3836
go away
Thought the symptom was 231 (33.4%) 197 ± 798 31 0–9486
not serious
Scared 34 (4.9%) 102 ± 191 26.5 0–762
Didn’t have time to seek help 25 (3.6%) 29 ± 40 14 0–123
Other reasons 317 (48.8%) 77 ± 648 2 0–10958
Total 692 (100.0%) 267 80.2those who failed to keep their appointment tended to be processed
more slowly by the system. Predictors of decreased system delay
included subsequent cancer diagnosis, patients’ attribution of
cancer to their symptom and presence of a breast lump at the time
of referral. Other socio-demographic factors including age, socio-
economic status and ethnicity, were not important predictors.
We investigated the variables predictive of a positive cancer
diagnosis using logistic regression (R2 = 0.36). After correcting for
age and demographic variables, the main results were that women
later diagnosed with breast cancer were more likely to have a
delayed presentation due to fear than those with benign disease,
OR 2.69 (95% CI 0.98–6.9), to have thought their symptom was
due to cancer, OR 2.50 (95% CI 1.4–4.6), and were significantly
less likely to have had a screening mammogram OR 2.28 (95% 
CI 1.06–5.0).
DISCUSSION
Patient delay
Based on a large consecutive series of symptomatic women
attending a hospital breast clinic, we found that psychological
rather than demographic factors (Antonowsky and Hartman, 1974;
Williams et al, 1976; Burgess et al, 1998) were the main predictors
of delay in presentation of 4 weeks or more. Ethnicity did not
significantly influence either patient or system delay, in contrast to
reports from the USA (Richardson et al, 1992; Hunter et al, 1993),
and marital status was not found to influence delay (see also
Ramirez et al, 1999).
Others have taken 3 months as the criterion for long delay.
Relatively few patients in this and another recent UK survey
(Burgess et al, 1998) delayed for this long, moreover, the factors
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Table 4 Reasons for patient delay for long delayers only (>27 days), by diagnosis
Reason for delay Frequency
Benign Cancer
Thought the symptom would go away 35 (16.2%) 7 (25.9%)
Thought the symptom was not serious 116 (53.7%) 11 (40.7%)
Scared 11 (5.1%) 6 (22.2%)
Didn’t have time to seek help 6 (2.8%) 1 (3.7%)
Other reasons 48 (22.2%) 2 (7.4%)
Total 216 (88.9%) 27 (11.1%)
c2 for heterogeneity = 14.78, df = 4, P = 0.005.
Table 5 Modelling patient delay (>27 days) for the whole sample, using logistic regression analysis.
Variable Parameter P c2 Odds 95% Confidence
estimate ratio intervals
Increase in GHQ score of one unit 0.04 0.03 1.04 1.00–1.09
Would tend to delay presentation 0.03 0.002 1.03 1.01–1.05
with physical symptoms
Delayed because she thought the 1.44 0.001 4.23 2.50–7.20
symptom would go away
Delayed because she thought the 1.81 0.001 6.10 4.11–9.17
symptom not serious
Delayed because she was scared 1.57 0.0001 4.79 2.25–10.24
Lump was a presenting symptom –0.33 0.09 0.72 0.49–1.06
Pain was a presenting symptom –0.46 0.08 0.63 0.38–1.06
R2 = 0.18, Max-rescaled R2 = 0.25.
Table 6 Modelling system delay for the whole sample using multiple regression analysis.
Variable Parameter P c2 % contribution 
estimate to R2
Increase of 1 in log (patient delay (days) + 1) 0.05 0.016 8.8
Did not attend outpatient appointment 0.40 0.0001 29.0
Turned out to have cancer –0.13 0.006 18.2
Thought symptom was cancerous –0.08 0.039 11.6
Had a breast lump at the time of referral –0.09 0.01 10.0
to the clinic
R2 = 0.11.related to 4 weeks or more delay were also related to delay of 3
months. Additional factors emerged with longer delays such as
preference for a female consultant, also highlighted in relation to
attitudes to breast examination (Haigney et al, 1997). Another was
having had a recent consultation with the GP, which may have
inhibited patients from ‘bothering’ the doctor again.
Psychological distress – as indexed by an expression of fear of
cancer and by GHQ scores – was associated with long delays,
especially in those who did indeed turn out to have breast cancer.
Not unexpectedly, those least anxious about their symptoms also
delayed seeking medical attention. This pattern is predicted by an
arousal model of human behaviour (Tones, 1980). Anxiety and
depression were assessed at interview, so may also have coloured
explanations given for previous behaviour and may be different
from that at the time of symptom discovery. Similarly, patients’
tendency to procrastinate when faced with the hypothetical
scenario of discovering a breast lump, was inferred retrospectively
with respect to patient delay, from the Health Awareness
Assessment.
Health education campaigns state that a breast lump is a
possible indicator of breast cancer. The proportion of women 
actually presenting with such a symptom in this study was 61%.
Women with lumps had less patient and system delay, supporting
our hypothesis and previous studies (MacArthur and Smith, 1981;
Gould-Martin et al, 1982).
Nine out of 10 women (497/529) attending the clinic thinking
they had a benign condition were correct, and two out of three
women (108/163) who suspected they had cancer were incorrect.
Nevertheless, women later diagnosed with breast cancer seemed to
have a strong inkling that this was the case prior to definitive tissue
diagnosis; they were interviewed after having seen a primary care
practitioner, who may have cued them to the suspicion of malig-
nancy. Despite this and contrary to previous studies (Greer, 1974)
most of the women in this study subsequently diagnosed with
breast cancer did not present earlier than those with a benign
condition and a few delayed presentation to a worrying degree,
citing fear of diagnosis as an explanation. Overall, the results
suggest that factors causing delay are the same in those who
develop cancer and those who do not.
A relationship between delay in symptomatic presentation and
compliance with mammographic screening might have been
expected since the psychological processes involved appear to
overlap (Fink, 1977). Our data on mammograms were based
entirely on self reports so may not have been reliable. However, no
such relationship was detected. Some women claimed not to have
received an offer of screening and this may have been the result of
administrative failures. The current study was restricted to those
who had symptoms although it covered an age range which
included that which is targeted for screening (50–64 years).
Caution is needed before extrapolating our findings to women
diagnosed through screening or other age groups; indeed
restricting our sample to those of 75 years of age or less may have
obscured a relationship between age and delay found in a recent
systematic review (Ramirez et al, 1999). Furthermore, differences
in patient (and system) delay in other groups, such as those with
and without a positive family history were not detected.
System delay
This was not predicted by socio-demographic variables and our
model succeeded in explaining only 11% of the variance. System
delay was predicted by increased patient delay and missed
appointments. Failure to attend an outpatient appointment may,
however, be due in part to administrative complications, such as
incorrect addresses. Further audit of this is necessary. The system
we studied did not show a social class, ethnic or education bias.
Furthermore, apart from a few unfortunate exceptions where
patients appeared to have been falsely reassured, i.e. not referred
on immediately, the system responded appropriately more quickly
to patients who turned out to have cancer.
What are the implications from this study for health promotion?
There is a delicate balance between scaring women away from
their doctors on the one hand (especially when they suspect the
worst), and adding to a false sense of reassurance, thus taking
away any motivation to come forward. Women should be encour-
aged to think of their breast symptom as ‘urgent but not neces-
sarily serious’ and should be prompted to present to their doctor as
soon as possible. Diagnosis should be cast in as positive a light as
possible. Although breast lumps are the most common symptom,
others are also predictive of cancer and perhaps these should be
mentioned in health awareness campaigns. Regarding system
delay, administrative arrangements should be regularly monitored
in terms of national targets. The availability of female consultants
should be increased to meet patient preferences. Finally, health
care professionals should be alert to women who are hesitant to
present, and in such circumstances should themselves act swiftly.
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